Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3205 S Russell St
Missoula, MT 59801Phone+1 406-721-4906Fax+1 406-447-7916
Summary
- Dr. Anthony D'Amico, MD is a board certified radiologist in Missoula, Montana. He is currently licensed to practice medicine in Montana, Washington, and Arizona. He is a Professor of Radiation Oncology at Brigham and Women's Hospital.
Education & Training
University of Washington School of MedicineClass of 2002
Certifications & Licensure
MT State Medical License 2007 - 2025
WA State Medical License 2017 - 2025
AZ State Medical License 2007 - 2010
OH State Medical License 2007 - 2009
TN State Medical License 2007 - 2009
IL State Medical License 2007 - 2008
KY State Medical License 2007 - 2008
American Board of Radiology Diagnostic Radiology- American Board of Radiology Neuroradiology
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsReply to G. Francolini et al.Anthony V. D'Amico, Wanling Xie, Philip W. Kantoff
Journal of Clinical Oncology. 2021-09-17 - 32 citationsRadiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Pr...Jonathan E. Leeman, Yu-Hui Chen, Paul J. Catalano, Jeremy S. Bredfeldt, Martin T. King
International Journal of Radiation Oncology, Biology, Physics. 2021-08-16 - 5 citationsSecond malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques.Edward Christopher Dee, Vinayak Muralidhar, Martin T King, Neil E Martin, Anthony V D'Amico
Radiotherapy and Oncology. 2021-08-01
Press Mentions
New Findings Could Change Treatment Practice and Lengthen Survival for Men with pN1 Prostate CancerMarch 15th, 2022- Anthony D'Amico, MD, on Docetaxel in Men with Unfavorable-Risk Prostate CancerNovember 3rd, 2021
- Anthony D'Amico, MD, PhD, on Adjuvant vs Early Salvage RTSeptember 22nd, 2021
- Join now to see all
